2025/06/01 更新

所属以外の情報はresearchmapへの登録情報を転載しています。

写真a

クニイ ミサコ
國井 美紗子
Misako Kunii
所属
附属市民総合医療センター 脳神経内科 講師
職名
講師
外部リンク

学位

  • 博士(医学) ( 横浜市立大学 )

研究分野

  • ライフサイエンス / 神経内科学

経歴

  • 横浜市立大学   神経内科・脳卒中科

    2014年4月 - 現在

      詳細を見る

論文

  • Siponimod inhibits microglial inflammasome activation. 国際誌

    Hiroyasu Komiya, Hideyuki Takeuchi, Akihiro Ogasawara, Yuki Ogawa, Shun Kubota, Shunta Hashiguchi, Keita Takahashi, Misako Kunii, Kenichi Tanaka, Mikiko Tada, Hiroshi Doi, Fumiaki Tanaka

    Neuroscience research   2025年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Siponimod is the first oral drug approved for active secondary progressive multiple sclerosis. It acts as a functional antagonist of sphingosine-1-phosphate (S1P) receptor 1 (S1P1) through S1P1 internalization, and also serves an agonist of S1P5; however, the detailed mechanisms of its therapeutic effects on glial cells have yet to be elucidated. In this study, we investigated the anti-inflammatory mechanism of siponimod in microglia. Pretreatment with either siponimod or the S1P1 antagonist W146 significantly suppressed the production of interleukin-1β in activated microglia stimulated with lipopolysaccharide plus nigericin, an inflammasome activator. Furthermore, siponimod treatment reduced the protein levels of cleaved caspase-1 and inhibited the formation of aggregates of apoptosis-associated speck-like protein containing a C-terminal caspase recruitment domain (ASC specks) in microglia. Our data indicate that siponimod achieves its anti-inflammatory effects by inhibiting inflammasome activation in microglia via S1P1 antagonism. This process is inferred to play a crucial role in mitigating the secondary progression of multiple sclerosis, where microglial activation in the gray matter is considered a key pathological factor.

    DOI: 10.1016/j.neures.2025.02.002

    PubMed

    researchmap

  • A case report of an individual with Creutzfeldt-Jakob disease characterized by prolonged isolated thalamic lesions and rare MM2-cortical-type pathology. 国際誌

    Misako Kunii, Hitaru Kishida, Mikiko Tada, Mitsuo Okamoto, Keiichiro Asano, Haruko Nakamura, Keita Takahashi, Shunta Hashiguchi, Shun Kubota, Masaki Okubo, Hideyuki Takeuchi, Naohisa Ueda, Katsuya Satoh, Tetsuyuki Kitamoto, Hiroshi Doi, Fumiaki Tanaka

    BMC neurology   24 ( 1 )   456 - 456   2024年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Diffusion-weighted magnetic resonance imaging (DWI) is essential for diagnosing Creutzfeldt-Jakob disease (CJD). Thalamic lesions are rarely detected by DWI in sporadic CJD (sCJD) cases with methionine homozygosity at polymorphic codon 129 (129MM) of the prion protein (PrP) gene. Here, we describe an unusual sCJD case, characterized by prolonged isolated thalamic diffusion hyperintensities and atypical brain pathology, in combination with the 129MM genotype. CASE PRESENTATION: A 72-year-old Japanese man developed a mild unsteady gait that had persisted for 1 year. DWI revealed isolated thalamic diffusion hyperintensities. Over the following 4 years, his condition progressed to include ataxia and cognitive decline. Repeated cerebrospinal fluid tests were negative for 14-3-3 protein, total tau protein, and real-time quaking-induced conversion assay. Electroencephalography did not show periodic sharp wave complexes or generalized periodic discharges. Despite these findings, thalamic DWI abnormalities persisted and evolved to include cortical lesions in the later stage of the disease. Genetic testing confirmed a 129MM genotype with no pathogenic PrP gene variants. Brain autopsy identified type 2 pathogenic PrP and the absence of the M2-thalamic prion strain, suggesting an MM2-cortical (MM2C)-subtype of sCJD. Histopathology revealed small vacuoles (sv) and patchy-perivacuolar PrP deposits without large vacuoles (lv). Patchy-perivacuolar deposits are a characteristic feature of the MM2C (lv) subtype and indicate MM2C (lv) pathology. Thus, this case was classified as a rare MM2C (sv + lv) subtype. No PrP protein staining was observed in the thalamus, despite spongiform changes with small vacuoles. CONCLUSIONS: This case underscores the diagnostic challenges of atypical CJD with isolated thalamic abnormalities on DWI. Despite negative cerebrospinal fluid findings and clinical diagnostic criteria, persistent DWI abnormalities and evolving clinical symptoms continued to raise suspicion of CJD. A definitive diagnosis, being the MM2C (sv + lv) subtype of sCJD, was confirmed upon pathological examination. Even when atypical findings, such as isolated thalamic abnormalities, are observed and various tests are negative, if suspicion of CJD cannot be ruled out, it is important to confirm the diagnosis and pathological subtypes via postmortem analysis.

    DOI: 10.1186/s12883-024-03958-9

    PubMed

    researchmap

  • Complete nanopore repeat sequencing of SCA27B (GAA-FGF14 ataxia) in Japanese. 国際誌

    Satoko Miyatake, Hiroshi Doi, Hiroaki Yaguchi, Eriko Koshimizu, Naoki Kihara, Tomoyasu Matsubara, Yasuko Mori, Kenjiro Kunieda, Yusaku Shimizu, Tomoko Toyota, Shinichi Shirai, Masaaki Matsushima, Masaki Okubo, Taishi Wada, Misako Kunii, Ken Johkura, Ryosuke Miyamoto, Yusuke Osaki, Takabumi Miyama, Mai Satoh, Atsushi Fujita, Yuri Uchiyama, Naomi Tsuchida, Kazuharu Misawa, Kohei Hamanaka, Haruka Hamanoue, Takeshi Mizuguchi, Hiroyuki Morino, Yuishin Izumi, Takayoshi Shimohata, Kunihiro Yoshida, Hiroaki Adachi, Fumiaki Tanaka, Ichiro Yabe, Naomichi Matsumoto

    Journal of neurology, neurosurgery, and psychiatry   2024年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Although pure GAA expansion is considered pathogenic in SCA27B, non-GAA repeat motif is mostly mixed into longer repeat sequences. This study aimed to unravel the complete sequencing of FGF14 repeat expansion to elucidate its repeat motifs and pathogenicity. METHODS: We screened FGF14 repeat expansion in a Japanese cohort of 460 molecularly undiagnosed adult-onset cerebellar ataxia patients and 1022 controls, together with 92 non-Japanese controls, and performed nanopore sequencing of FGF14 repeat expansion. RESULTS: In the Japanese population, the GCA motif was predominantly observed as the non-GAA motif, whereas the GGA motif was frequently detected in non-Japanese controls. The 5'-common flanking variant was observed in all Japanese GAA repeat alleles within normal length, demonstrating its meiotic stability against repeat expansion. In both patients and controls, pure GAA repeat was up to 400 units in length, whereas non-pathogenic GAA-GCA repeat was larger, up to 900 units, but they evolved from different haplotypes, as rs534066520, located just upstream of the repeat sequence, completely discriminated them. Both (GAA)≥250 and (GAA)≥200 were enriched in patients, whereas (GAA-GCA)≥200 was similarly observed in patients and controls, suggesting the pathogenic threshold of (GAA)≥200 for cerebellar ataxia. We identified 14 patients with SCA27B (3.0%), but their single-nucleotide polymorphism genotype indicated different founder alleles between Japanese and Caucasians. The low prevalence of SCA27B in Japanese may be due to the lower allele frequency of (GAA)≥250 in the Japanese population than in Caucasians (0.15% vs 0.32%-1.26%). CONCLUSIONS: FGF14 repeat expansion has unique features of pathogenicity and allelic origin, as revealed by a single ethnic study.

    DOI: 10.1136/jnnp-2024-333541

    PubMed

    researchmap

  • Anti-epileptic drug use and subsequent degenerative dementia occurrence. 国際誌

    Naoki Ikegaya, Honoka Nakamura, Yutaro Takayama, Yohei Miyake, Takahiro Hayashi, Masaki Sonoda, Mitsuru Sato, Kensuke Tateishi, Jun Suenaga, Masao Takaishi, Yu Kitazawa, Misako Kunii, Hiroki Abe, Tomoyuki Miyazaki, Tetsuaki Arai, Manabu Iwasaki, Takayuki Abe, Tetsuya Yamamoto

    Alzheimer's & dementia (New York, N. Y.)   10 ( 3 )   e70001   2024年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    INTRODUCTION: The use of anti-epileptic drugs (AEDs) in degenerative dementia (DD) remains uncertain. We aimed to evaluate the association of early AED administration with subsequent DD occurrence. METHODS: Using a large nationwide database, we enrolled patients newly diagnosed with epilepsy from 2014 to 2019 (n = 104,225), and using propensity score matching, we divided them into treatment (those prescribed AEDs in 2014) and control groups. The primary outcome was subsequent DD occurrence in 2019. RESULTS: Overall, 4489 pairs of patients (2156 women) were matched. The odds ratio (treatment/control) for DD occurrence was 0.533 (95% confidence interval: 0.459-0.617). The DD proportions significantly differed between the treatment (340/4489 = 0.076) and control (577/4489 = 0.129) groups. DISCUSSION: Among patients newly diagnosed with epilepsy, compared to non-use, early AED use was associated with a lower occurrence of subsequent DD. Further investigations into and optimization of early intervention for epilepsy in DD are warranted. HIGHLIGHTS: Anti-epileptic drug (AED) use before epilepsy diagnosis was linked with a lower subsequent degenerative dementia (DD) occurrence.Identifying the epileptic phenotype was crucial for justifying early AED use in DD.AED use with an epilepsy diagnosis did not pose an additional risk of DD.The potential contribution of combination drug therapy to the strategy was noted.

    DOI: 10.1002/trc2.70001

    PubMed

    researchmap

  • Lateral olfactory tract usher substance (LOTUS), an endogenous Nogo receptor antagonist, ameliorates disease progression in amyotrophic lateral sclerosis model mice. 国際誌

    Takuya Ikeda, Keita Takahashi, Minatsu Higashi, Hiroyasu Komiya, Tetsuya Asano, Akihiro Ogasawara, Shun Kubota, Shunta Hashiguchi, Misako Kunii, Kenichi Tanaka, Mikiko Tada, Hiroshi Doi, Hideyuki Takeuchi, Kohtaro Takei, Fumiaki Tanaka

    Cell death discovery   9 ( 1 )   454 - 454   2023年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Nogo-Nogo receptor 1 (NgR1) signaling is significantly implicated in neurodegeneration in amyotrophic lateral sclerosis (ALS). We previously showed that lateral olfactory tract usher substance (LOTUS) is an endogenous antagonist of NgR1 that prevents all myelin-associated inhibitors (MAIs), including Nogo, from binding to NgR1. Here we investigated the role of LOTUS in ALS pathogenesis by analyzing G93A-mutated human superoxide dismutase 1 (SOD1) transgenic (Tg) mice, as an ALS model, as well as newly generated LOTUS-overexpressing SOD1 Tg mice. We examined expression profiles of LOTUS and MAIs and compared motor functions and survival periods in these mice. We also investigated motor neuron survival, glial proliferation in the lumbar spinal cord, and neuromuscular junction (NMJ) morphology. We analyzed downstream molecules of NgR1 signaling such as ROCK2, LIMK1, cofilin, and ataxin-2, and also neurotrophins. In addition, we investigated LOTUS protein levels in the ventral horn of ALS patients. We found significantly decreased LOTUS expression in both SOD1 Tg mice and ALS patients. LOTUS overexpression in SOD1 Tg mice increased lifespan and improved motor function, in association with prevention of motor neuron loss, reduced gliosis, increased NMJ innervation, maintenance of cofilin phosphorylation dynamics, decreased levels of ataxin-2, and increased levels of brain-derived neurotrophic factor (BDNF). Reduced LOTUS expression may enhance neurodegeneration in SOD1 Tg mice and ALS patients by activating NgR1 signaling, and in this study LOTUS overexpression significantly ameliorated ALS pathogenesis. LOTUS might serve as a promising therapeutic target for ALS.

    DOI: 10.1038/s41420-023-01758-7

    PubMed

    researchmap

  • RNA foci in two bi-allelic RFC1 expansion carriers. 国際誌

    Taishi Wada, Hiroshi Doi, Masaki Okubo, Mikiko Tada, Naohisa Ueda, Hidefumi Suzuki, Wakana Tominaga, Haruki Koike, Hiroyasu Komiya, Shun Kubota, Shunta Hashiguchi, Haruko Nakamura, Keita Takahashi, Misako Kunii, Kenichi Tanaka, Yosuke Miyaji, Yuichi Higashiyama, Eriko Koshimizu, Satoko Miyatake, Masahisa Katsuno, Satoshi Fujii, Hidehisa Takahashi, Naomichi Matsumoto, Hideyuki Takeuchi, Fumiaki Tanaka

    Annals of neurology   2023年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS) is a late-onset, autosomal recessive neurodegenerative disorder caused by biallelic AAGGG/ACAGG repeat expansion (AAGGG-exp/ACAGG-exp) in RFC1. The recent identification of patients with CANVAS exhibiting compound heterozygosity for AAGGG-exp and truncating variants supports the loss-of-function of RFC1 in CANVAS patients. We investigated the pathological changes in two autopsied patients with CANVAS harboring biallelic ACAGG-exp and AAGGG-exp. RNA fluorescence in situ hybridization of the two patients revealed CCTGT- and CCCTT-containing RNA foci, respectively, in neuronal nuclei of tissues with neuronal loss. Our findings suggest that RNA toxicity may be involved in the pathogenesis of CANVAS. This article is protected by copyright. All rights reserved.

    DOI: 10.1002/ana.26848

    PubMed

    researchmap

  • MRI拡散強調画像で両側視床高信号を呈したプリオン病の2症例

    岸田 日帯, 國井 美紗子, 多田 美紀子, 林 紀子, 木村 活生, 宮地 洋輔, 東山 雄一, 土井 宏, 竹内 英之, 上田 直久, 児矢野 繁, 北本 哲之, 田中 章景

    臨床神経学   63 ( Suppl. )   S325 - S325   2023年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 神経筋疾患の問題症例 経過7年の多発性単ニューロパチーを呈する44歳女性例 multifocal CIDPか?

    宮地 洋輔, 國井 美紗子, 古宮 裕泰, 田中 章景

    臨床神経生理学   50 ( 5 )   353 - 353   2022年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本臨床神経生理学会  

    researchmap

  • 神経筋疾患の問題症例 経過7年の多発性単ニューロパチーを呈する44歳女性例 multifocal CIDPか?

    宮地 洋輔, 國井 美紗子, 古宮 裕泰, 田中 章景

    臨床神経生理学   50 ( 5 )   353 - 353   2022年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本臨床神経生理学会  

    researchmap

  • Phosphorylated CRMP1, axon guidance protein, is a component of spheroids and is involved in axonal pathology in amyotrophic lateral sclerosis

    Yuko Kawamoto, Mikiko Tada, Tetsuya Asano, Haruko Nakamura, Aoi Jitsuki-Takahashi, Hiroko Makihara, Shun Kubota, Shunta Hashiguchi, Misako Kunii, Toshio Ohshima, Yoshio Goshima, Hideyuki Takeuchi, Hiroshi Doi, Fumio Nakamura, Fumiaki Tanaka

    Frontiers in Neurology   13   2022年9月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Frontiers Media SA  

    In amyotrophic lateral sclerosis (ALS), neurodegeneration is characterized by distal axonopathy that begins at the distal axons, including the neuromuscular junctions, and progresses proximally in a “dying back” manner prior to the degeneration of cell bodies. However, the molecular mechanism for distal axonopathy in ALS has not been fully addressed. Semaphorin 3A (Sema3A), a repulsive axon guidance molecule that phosphorylates collapsin response mediator proteins (CRMPs), is known to be highly expressed in Schwann cells near distal axons in a mouse model of ALS. To clarify the involvement of Sema3A–CRMP signaling in the axonal pathogenesis of ALS, we investigated the expression of phosphorylated CRMP1 (pCRMP1) in the spinal cords of 35 patients with sporadic ALS and seven disease controls. In ALS patients, we found that pCRMP1 accumulated in the proximal axons and co-localized with phosphorylated neurofilaments (pNFs), which are a major protein constituent of spheroids. Interestingly, the pCRMP1:pNF ratio of the fluorescence signal in spheroid immunostaining was inversely correlated with disease duration in 18 evaluable ALS patients, indicating that the accumulation of pCRMP1 may precede that of pNFs in spheroids or promote ALS progression. In addition, overexpression of a phospho-mimicking CRMP1 mutant inhibited axonal outgrowth in Neuro2A cells. Taken together, these results indicate that pCRMP1 may be involved in the pathogenesis of axonopathy in ALS, leading to spheroid formation through the proximal progression of axonopathy.

    DOI: 10.3389/fneur.2022.994676

    researchmap

  • Ocular flutter as the presenting manifestation of autoimmune glial fibrillary acidic protein astrocytopathy. 国際誌

    Taishi Wada, Yuichi Higashiyama, Misako Kunii, Takashi Jono, Takuo Kobayashi, Shun Kubota, Mikiko Tada, Makoto Hara, Akio Kimura, Hiroshi Doi, Hideyuki Takeuchi, Fumiaki Tanaka

    Clinical neurology and neurosurgery   219   107307 - 107307   2022年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    A 39-year-old man exhibited ocular flutter and cerebellar ataxia following a subacute disturbance of consciousness and partial seizure. He was diagnosed with autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy by tissue- and cell-based antibody assays. Brain single-photon emission computed tomography detected a significant increase in blood flow in the fastigial nucleus, a critical region for eye saccade control. Immunotherapies diminished the ocular flutter and reduced hyperperfusion in the fastigial nucleus. This case suggests that autoimmune GFAP astrocytopathy can cause ocular flutter and provides strong imaging evidence supporting the hypothesis that ocular flutter is caused by hyperactivity or disinhibition of the fastigial nucleus.

    DOI: 10.1016/j.clineuro.2022.107307

    PubMed

    researchmap

  • Anti-inflammatory effects of siponimod on astrocytes

    Akihiro Ogasawara, Hideyuki Takeuchi, Hiroyasu Komiya, Yuki Ogawa, Koki Nishimura, Shun Kubota, Shunta Hashiguchi, Keita Takahashi, Misako Kunii, Kenichi Tanaka, Mikiko Tada, Hiroshi Doi, Fumiaki Tanaka

    Neuroscience Research   2022年8月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier BV  

    DOI: 10.1016/j.neures.2022.08.003

    researchmap

  • Inhibition of Crmp1 phosphorylation at Ser522 ameliorates motor function and neuronal pathology in amyotrophic lateral sclerosis model mice. 国際誌

    Tetsuya Asano, Haruko Nakamura, Yuko Kawamoto, Mikiko Tada, Yayoi Kimura, Hiroshi Takano, Ryoji Yao, Hiroya Saito, Takuya Ikeda, Hiroyasu Komiya, Shun Kubota, Shunta Hashiguchi, Keita Takahashi, Misako Kunii, Kenichi Tanaka, Yoshio Goshima, Fumio Nakamura, Hideyuki Takeuchi, Hiroshi Doi, Fumiaki Tanaka

    eNeuro   9 ( 3 )   2022年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Amyotrophic lateral sclerosis (ALS) is a rapidly progressive and fatal neurodegenerative disorder that affects upper and lower motor neurons; however, its pathomechanism has not been fully elucidated. Using a comprehensive phosphoproteomic approach, we have identified elevated phosphorylation of collapsin response mediator protein 1 (Crmp1) at serine 522 in the lumbar spinal cord of ALS model mice overexpressing a human superoxide dismutase mutant (SOD1G93A). We investigated the effects of Crmp1 phosphorylation and depletion in SOD1G93A mice using Crmp1S522A (Ser522→Ala) knockin (Crmp1ki/ki ) mice in which the S522 phosphorylation site was abolished and Crmp1 knockout (Crmp1 -/-) mice, respectively. Crmp1ki/ki/SOD1G93A mice showed longer latency to fall in a rotarod test while Crmp1-/-/SOD1G93A mice showed shorter latency compared with SOD1G93A mice. Survival was prolonged in Crmp1ki/ki/SOD1G93A mice but not in Crmp1-/-/SOD1G93A mice. In agreement with these phenotypic findings, residual motor neurons and innervated neuromuscular junctions were comparatively well-preserved in Crmp1ki/ki/SOD1G93A mice without affecting microglial and astroglial pathology. Pathway analysis of proteome alterations showed that the sirtuin signaling pathway had opposite effects in Crmp1ki/ki/SOD1G93A and Crmp1-/-/SOD1G93A mice. Our study indicates that modifying CRMP1 phosphorylation is a potential therapeutic strategy for ALS.Significance StatementCollapsin response mediator protein 1 (CRMP1) is an intracellular molecule that mediates semaphorin 3A (Sema3A) signaling. Phosphoproteomic analysis showed that the Semaphorin Neuronal Repulsive Signaling Pathway, which includes Crmp1 phosphorylation at Ser522, is upregulated in SOD1G93A mice that serve as a model of amyotrophic lateral sclerosis (ALS). While deleting both copies of the Crmp1 gene (Crmp1-/- ) leads to deterioration of motor function in SOD1G93A mice, phospho-null Crmp1 (Crmp1ki/ki ) improves motor function while preventing motor neuron loss and denervation of neuromuscular junctions. Among the Sema3A-mediated axon guidance pathways, we propose that CRMP1 phosphorylation is a potential therapeutic target for ALS.

    DOI: 10.1523/ENEURO.0133-22.2022

    PubMed

    researchmap

  • 腋窩多汗症に対するボツリヌス毒素局注療法後に広範な筋無力症状を呈した50歳女性例

    城野 誉士, 東山 雄一, 宮地 洋輔, 窪田 瞬, 國井 美紗子, 多田 美紀子, 竹内 英之, 田中 章景

    臨床神経学   62 ( 4 )   317 - 317   2022年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 発熱・意識障害で発症し、経過中にocular flutterを呈した抗GFAP抗体陽性髄膜脳炎の39歳男性例

    和田 大司, 東山 雄一, 高橋 慶太, 國井 美紗子, 木村 暁夫, 原 誠, 竹内 英之, 田中 章景

    臨床神経学   62 ( 1 )   80 - 80   2022年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Association between neurosarcoidosis with autonomic dysfunction and anti-ganglionic acetylcholine receptor antibodies. 国際誌

    Makoto Oishi, Akihiro Mukaino, Misako Kunii, Asami Saito, Yukimasa Arita, Haruki Koike, Osamu Higuchi, Yasuhiro Maeda, Norio Abiru, Naohiro Yamaguchi, Hiroaki Kawano, Eiko Tsuiki, Tomonori Tanaka, Hidenori Matsuo, Masahisa Katsuno, Fumiaki Tanaka, Akira Tsujino, Shunya Nakane

    Journal of neurology   268 ( 11 )   4265 - 4279   2021年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    OBJECTIVE: To determine whether autonomic dysfunction in neurosarcoidosis is associated with anti-ganglionic acetylcholine receptor (gAChR) antibodies, which are detected in autoimmune autonomic ganglionopathy. METHODS: We retrospectively extracted cases of sarcoidosis from 1787 serum samples of 1,381 patients between 2012 and 2018. Anti-gAChR antibodies against the α3 and β4 subunit were measured by luciferase immunoprecipitation to confirm the clinical features of each case. We summarized literature reviews of neurosarcoidosis with severe dysautonomia to identify relevant clinical features and outcomes. RESULTS: We extracted three new cases of neurosarcoidosis with severe dysautonomia, among which two were positive for anti-gAChR antibodies: Case 1 was positive for antibodies against the β4 subunit, and Case 2 was positive for antibodies against both the α3 and β4 subunits. We reviewed the cases of 15 patients with neurosarcoidosis and severe dysautonomia, including the three cases presented herein. Orthostatic hypotension and orthostatic intolerance were the most common symptoms. Among the various types of neuropathy, small fiber neuropathy (SFN) was the most prevalent, with seven of nine cases exhibiting definite SFN. Six of eight cases had impaired postganglionic fibers, of which the present three cases revealed abnormality of 123I-MIBG myocardial scintigraphy. Of the 11 cases, 10 were responsive to immunotherapy, except one seropositive case (Case 2). CONCLUSIONS: The presence of gAChR antibodies may constitute one of the mechanisms by which dysautonomia arises in neurosarcoidosis.

    DOI: 10.1007/s00415-021-10551-4

    PubMed

    researchmap

  • SGTA associates with intracellular aggregates in neurodegenerative diseases. 国際誌

    Shun Kubota, Hiroshi Doi, Shigeru Koyano, Kenichi Tanaka, Hiroyasu Komiya, Atsuko Katsumoto, Shingo Ikeda, Shunta Hashiguchi, Haruko Nakamura, Ryoko Fukai, Keita Takahashi, Misako Kunii, Mikiko Tada, Hideyuki Takeuchi, Fumiaki Tanaka

    Molecular brain   14 ( 1 )   59 - 59   2021年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Intracellular aggregates are a common pathological hallmark of neurodegenerative diseases such as polyglutamine (polyQ) diseases, amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD), and multiple system atrophy (MSA). Aggregates are mainly formed by aberrant disease-specific proteins and are accompanied by accumulation of other aggregate-interacting proteins. Although aggregate-interacting proteins have been considered to modulate the formation of aggregates and to be involved in molecular mechanisms of disease progression, the components of aggregate-interacting proteins remain unknown. In this study, we showed that small glutamine-rich tetratricopeptide repeat-containing protein alfa (SGTA) is an aggregate-interacting protein in neurodegenerative diseases. Immunohistochemistry showed that SGTA interacted with intracellular aggregates in Huntington disease (HD) cell models and neurons of HD model mice. We also revealed that SGTA colocalized with intracellular aggregates in postmortem brains of patients with polyQ diseases including spinocerebellar ataxia (SCA)1, SCA2, SCA3, and dentatorubral-pallidoluysian atrophy. In addition, SGTA colocalized with glial cytoplasmic inclusions in the brains of MSA patients, whereas no accumulation of SGTA was observed in neurons of PD and ALS patients. In vitro study showed that SGTA bound to polyQ aggregates through its C-terminal domain and SGTA overexpression reduced intracellular aggregates. These results suggest that SGTA may play a role in the formation of aggregates and may act as potential modifier of molecular pathological mechanisms of polyQ diseases and MSA.

    DOI: 10.1186/s13041-021-00770-1

    PubMed

    researchmap

  • Exploratory investigation on antibodies to GluN1 and cognitive dysfunction in patients with chronic autoimmune psychosis. 国際誌

    Kie Abe, Yuhei Chiba, Omi Katsuse, Yukitoshi Takahashi, Akira Suda, Saki Hattori, Ryusuke Yoshimi, Yohei Kirino, Misako Kunii, Asuka Yoshimi, Takeshi Asami, Akitoyo Hishimoto

    Neuroscience letters   743   135588 - 135588   2021年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    INTRODUCTION: Mild cognitive dysfunction has been implicated in a number of psychiatric diseases and affects social functioning. Although clinical criteria were recently proposed for autoimmune psychosis (AP), biomarkers have not yet been established for the severity and prognosis of cognitive dysfunction. We herein investigated the relationships between 3 types of serum antibodies and cognitive dysfunction in chronic psychiatric patients suspected of AP. METHODS: We included 31 patients suspected of AP and obtained information on their clinical characteristics. Three types of autoantibodies (the anti-N-methyl-D-aspartate receptor (anti-NMDAR Ab), anti-N-terminal of GluN1 (anti-GluN1-NT Ab), and anti-thyroid antibodies) were evaluated in serum. Cognitive function was assessed using Wechsler Adult Intelligence Scale-III. We examined the relationships between serum autoantibodies and cognitive dysfunction in patients using multiple regression models. RESULTS: Serum titers of anti-GluN1-NT Ab significantly contributed to the estimated score of working memory (B= -55.85, β= -0.46, p= 0.01), while no correlation was observed between the other 2 types of antibodies and cognitive function. CONCLUSIONS: The present results indicate the potential of serum anti-GluN1-NT Ab as a biomarker for the severity and prognosis of cognitive dysfunction underlying various psychiatric symptoms in patients with AP. The pathological significance of anti-GluN1-NT Ab needs to be verified in future studies.

    DOI: 10.1016/j.neulet.2020.135588

    PubMed

    researchmap

  • 多発脳神経麻痺と左上肢の筋力低下を認め、腕神経叢生検により診断し得たNeurolymphomatosisの80歳男性例

    小林 卓雄, 東山 雄一, 窪田 瞬, 國井 美紗子, 多田 美紀子, 竹内 英之, 田中 章景

    臨床神経学   61 ( 1 )   67 - 67   2021年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Case Report: Severe Osteoporosis and Preventive Therapy in RNA Polymerase III-Related Leukodystrophy. 国際誌

    Soma Furukawa, Misako Kunii, Hiroshi Doi, Naohide Kondo, Aya Ogura, Koichi Hirabuki, Takayuki Itoh, Naomichi Matsumoto, Fumiaki Tanaka, Masahisa Katsuno, Yasuhiro Ito

    Frontiers in neurology   12   622355 - 622355   2021年

     詳細を見る

    記述言語:英語  

    RNA polymerase III (POLR3)-related leukodystrophy is an autosomal recessive form of leukodystrophy caused by homozygous or compound heterozygous mutations of the RNA polymerase III subunit genes, including subunit A (POLR3A). With respect to the manifestation triad, hypomyelination, hypodontia, and hypogonadotropic hypogonadism, it is also known as 4H leukodystrophy. Here, we report a 41-year-old woman of POLR3-related leukodystrophy by carrying compound heterozygous pathogenic variants of c.2554A>G (p.M852V) and c.2668G>T (p.V890F) in the POLR3A gene. She was amenorrheic and became a wheelchair user from the age of 15 years and suffered from multiple episodes of pathologic fractures, starting with a subtrochanteric fracture of the right femur after a tonic seizure at age 30 years. Head magnetic resonance imaging demonstrated hypomyelination and atrophies of the cerebellum, brainstem, and corpus callosum. Laboratory examination revealed a marked decrease of gonadotropins and estrogen, low bone density, and high bone resorption markers. Administration of anti-receptor activator of nuclear factor kappa-B ligand monoclonal antibody restored bone resorption markers to a normal level and prevented further pathological bone fractures. Our case emphasizes that osteoporosis should be recognized as a potential but serious complication in POLR3-related leukodystrophy. It may be feasible to prevent pathologic fractures by intensive osteoporosis therapy after endocrinological examinations and evaluation of bone metabolism.

    DOI: 10.3389/fneur.2021.622355

    PubMed

    researchmap

  • Hepatitis B Virus-related Vasculitic Neuropathy in an Inactive Virus Carrier Treated with Intravenous Immunoglobulin.

    Kaori Kusama, Yoshiharu Nakae, Mikiko Tada, Yuichi Higashiyama, Yosuke Miyaji, Genpei Yamaura, Misako Kunii, Kenichi Tanaka, Ken Ohyama, Haruki Koike, Hideto Joki, Hiroshi Doi, Shigeru Koyano, Fumiaki Tanaka

    Internal medicine (Tokyo, Japan)   59 ( 23 )   3075 - 3078   2020年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    We herein report a 33-year-old woman who was an asymptomatic hepatitis B virus (HBV) carrier and presented with distal muscle weakness in the legs and asymmetrical paresthesia in the distal extremities. A nerve biopsy specimen revealed fibrinoid necrosis associated with inflammatory infiltration in the perineural space, and deposition of hepatitis B core antigen and C4d complement was detected in the vascular endothelial cells as well as around the vessels. She was diagnosed with HBV-related vasculitic neuropathy and treated with intravenous immunoglobulin (IVIG). Her symptoms completely subsided after eight weeks. Vasculitic neuropathy rarely develops in the chronic inactive stages of HBV infection. This is the first report of an HBV-inactive carrier with vasculitic neuropathy successfully treated with IVIG.

    DOI: 10.2169/internalmedicine.4498-20

    PubMed

    researchmap

  • 腋窩多汗症に対するA型ボツリヌス毒素局注療法後に広範な筋無力症状を認めた1例

    城野 誉士, 宮地 洋輔, 東山 雄一, 小林 卓雄, 和田 大司, 窪田 瞬, 國井 美紗子, 多田 美紀子, 竹内 英之, 土井 宏, 田中 章景

    臨床神経生理学   48 ( 5 )   597 - 597   2020年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本臨床神経生理学会  

    researchmap

  • ALSモデルマウスの病勢進行に伴ったCCR2の中枢神経における細胞局在変化

    古宮 裕泰, 竹内 英之, 小川 有紀, 高橋 慶太, 勝元 敦子, 國井 美紗子, 多田 美紀子, 土井 宏, 田中 章景

    神経免疫学   25 ( 1 )   110 - 110   2020年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経免疫学会  

    researchmap

  • [A case of subacute hypertrophic pachymeningitis caused by Pseudomonas aeruginosa infection presenting with subdural hygroma].

    Misako Kunii, Mitsuo Okamoto, Dan Takei, Shun Kubota, Haruko Nakamura, Fumiaki Tanaka

    Rinsho shinkeigaku = Clinical neurology   60 ( 8 )   538 - 542   2020年8月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    A 78-year-old woman with bilateral fungal sinusitis, which resulted in right orbital apex syndrome, underwent endoscopic sinus surgery and optic nerve decompression. Two months after the operation, she complained of anxiety and insomnia. Head CT showed subdural hematoma-like effusion and burr hole drainage was conducted. The collected fluid was not hematoma, but bloody, xanthochromic effusion with no pathogenic bacteria. Ten days later, she underwent drainage and dural biopsy after craniotomy because of relapse of subdural hygroma and progression of hypertrophic pachymeningitis associated with aggravation of psychiatric symptoms. A sample of the dura mater showed dense fibrosis with thickening, and Pseudomonas aeruginosa (P. aeruginosa) was detected by culture. Although otitis or sinusitis secondary to P. aeruginosa infection has been reported as a leading cause of infectious pachymeningitis, psychiatric symptoms alone and concomitant refractory subdural hygroma are atypical and unreported manifestations. In patients with pachymeningitis and a history of transnasal endoscopic surgery, P. aeruginosa infection should be considered, irrespective of an atypical clinical course and negative blood or fluid culture. Additionally, dural biopsy might help in detection of pathogenic bacteria.

    DOI: 10.5692/clinicalneurol.60.cn-001418

    PubMed

    researchmap

  • 緑膿菌感染による肥厚性硬膜炎に伴い硬膜下水腫を呈した1例

    國井 美紗子, 岡本 光生, 竹井 暖, 窪田 瞬, 中村 治子, 田中 章景

    臨床神経学   60 ( 8 )   538 - 542   2020年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    78歳女性.右眼窩先端症候群・両側真菌性副鼻腔炎に対する内視鏡下右視神経管開放術・副鼻腔手術施行2ヶ月後,精神症状,異常行動が出現した.当初右慢性硬膜下血腫の診断であったが,穿頭ドレナージ術により高蛋白の滲出液貯留が確認された.原因は不明であり,10日後に液体再貯留と硬膜肥厚を認めた.硬膜生検による組織培養にて初めて緑膿菌が検出され,レボフロキサシンの内服により軽快した.局所の緑膿菌感染に続発する肥厚性硬膜炎は,疼痛を初発症状とし進行すると脳神経麻痺などを呈する経過が典型的であるが,疼痛なしに硬膜下水腫を伴い亜急性の精神症状でのみ発症した症例は報告されておらず,本例は稀な症例と考えられた.(著者抄録)

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2020&ichushi_jid=J01550&link_issn=&doc_id=20200820280010&doc_link_id=130007885759&url=https%3A%2F%2Fci.nii.ac.jp%2Fnaid%2F130007885759&type=CiNii&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00003_1.gif

  • De novo CACNA1G variants in developmental delay and early-onset epileptic encephalopathies. 査読 国際誌

    Misako Kunii, Hiroshi Doi, Shunta Hashiguchi, Toyojiro Matsuishi, Yasunari Sakai, Mizue Iai, Masaki Okubo, Haruko Nakamura, Keita Takahashi, Atsuko Katsumoto, Mikiko Tada, Hideyuki Takeuchi, Taro Ishikawa, Noriko Miyake, Hirotomo Saitsu, Naomichi Matsumoto, Fumiaki Tanaka

    Journal of the neurological sciences   416   117047 - 117047   2020年7月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier BV  

    INTRODUCTION: Variants of CACNA1G, which encodes CaV3.1, have been reported to be associated with various neurological disorders. METHODS: Whole-exome sequencing of genomic DNA from 348 Japanese patients with neurodevelopmental disorders and their parents was conducted, and de novo variants of CACNA1G were extracted. The electrophysiological properties of each mutant channel were investigated by voltage-clamp and current-clamp analyses of HEK293T cells overexpressing these channels. RESULTS: Two patients diagnosed with Rett syndrome and West syndrome were found to have known pathological CACNA1G mutations reported in cerebellar ataxia cohorts: c.2881G > A, p.Ala961Thr and c.4591A > G, p.Met1531Val, respectively. One patient with Lennox-Gastaut syndrome was revealed to harbor a previously unreported heterozygous variant: c.3817A > T, p.Ile1273Phe. Clinical symptoms of the two patients with known mutations included severe developmental delay without acquisition of the ability to walk independently. The patient with a potentially novel mutation showed developmental delay, intractable seizures, and mild cerebral atrophy on MRI, but the severity of symptoms was milder than in the former two cases. Electrophysiological study using HEK293T cells demonstrated significant changes of T-type Ca2+ currents by p.Ala961Thr and p.Met1531Val SNVs, which were likely to enhance oscillation of membrane potential at low frequencies. In contrast, p.Ile1273Phe showed no significant effects in our electrophysiological evaluations, with its pathogenesis remaining undetermined. CONCLUSION: De novo variants of CACNA1G explain some neurodevelopmental disorders. Our study further provides information to understand the genotype-phenotype correlations of patients with CACNA1G mutations.

    DOI: 10.1016/j.jns.2020.117047

    PubMed

    researchmap

  • Reply to "GGC Repeat Expansion of NOTCH2NLC is Rare in European Leukoencephalopathy". 査読 国際誌

    Hiroshi Doi, Masaki Okubo, Ryoko Fukai, Atsushi Fujita, Satomi Mitsuhashi, Keita Takahashi, Misako Kunii, Mikiko Tada, Hiromi Fukuda, Takeshi Mizuguchi, Satoko Miyatake, Noriko Miyake, Jun Sone, Gen Sobue, Hideyuki Takeuchi, Naomichi Matsumoto, Fumiaki Tanaka

    Annals of neurology   88 ( 3 )   642 - 643   2020年6月

     詳細を見る

    記述言語:英語  

    DOI: 10.1002/ana.25819

    PubMed

    researchmap

  • CCR2 is localized in microglia and neurons, as well as infiltrating monocytes, in the lumbar spinal cord of ALS mice. 国際誌

    Hiroyasu Komiya, Hideyuki Takeuchi, Yuki Ogawa, Yuki Hatooka, Keita Takahashi, Atsuko Katsumoto, Shun Kubota, Haruko Nakamura, Misako Kunii, Mikiko Tada, Hiroshi Doi, Fumiaki Tanaka

    Molecular brain   13 ( 1 )   64 - 64   2020年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    It remains controversial whether circulating monocytes expressing CCR2 infiltrate the central nervous system (CNS) and contribute to pathogenicity of amyotrophic lateral sclerosis (ALS). A previous report used conventional immunohistochemistry to show that CCR2 is exclusively expressed by astrocytes, but not infiltrating monocytes/microglia or neurons, in the spinal cords of ALS model mice. In this study, we assessed the cellular distribution of CCR2 in the CNS of ALS mice using CCR2-reporter mice (Ccr2rfp/+-Cx3cr1gfp/+-SOD1G93A Tg mice), a more sophisticated method for directly detecting the distribution of CCR2 protein. We found that infiltration of CCR2+ monocytes in the lumbar spinal cord increased over the course of disease progression. Moreover, from the middle stage of disease, CCR2 was partially distributed in microglia and neurons, but not astrocytes, in striking contrast to the previous findings. These novel observations suggested that CCR2+ monocyte infiltration leads to CNS environmental deterioration due to toxic conversion of microglia and neurons, creating a vicious cycle of neuroinflammation and leading to acceleration of ALS pathology. Our findings also show that this reporter mouse is a useful and powerful tool for obtaining new insights into the pathomechanisms of ALS.

    DOI: 10.1186/s13041-020-00607-3

    PubMed

    researchmap

  • 2-ヒドロキシグルタル酸尿症による成人白質ジストロフィーの1例

    古田 恭寛, 邦武 克彦, 稲垣 良輔, 鈴木 淳一郎, 中井 紀嘉, 西田 卓, 伊藤 泰広, 國井 美紗子, 土井 宏, 田中 章景

    臨床神経学   60 ( 4 )   298 - 298   2020年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Long-read sequencing identifies the pathogenic nucleotide repeat expansion in RFC1 in a Japanese case of CANVAS. 査読 国際誌

    Haruko Nakamura, Hiroshi Doi, Satomi Mitsuhashi, Satoko Miyatake, Kazutaka Katoh, Martin C Frith, Tetsuya Asano, Yosuke Kudo, Takuya Ikeda, Shun Kubota, Misako Kunii, Yu Kitazawa, Mikiko Tada, Mitsuo Okamoto, Hideto Joki, Hideyuki Takeuchi, Naomichi Matsumoto, Fumiaki Tanaka

    Journal of human genetics   65 ( 5 )   475 - 480   2020年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Recently, a recessively inherited intronic repeat expansion in replication factor C1 (RFC1) was identified in cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome (CANVAS). Here, we describe a Japanese case of genetically confirmed CANVAS with autonomic failure and auditory hallucination. The case showed impaired uptake of iodine-123-metaiodobenzylguanidine and 123I-ioflupane in the cardiac sympathetic nerve and dopaminergic neurons, respectively, by single-photon emission computed tomography. Long-read sequencing identified biallelic pathogenic (AAGGG)n nucleotide repeat expansion in RFC1 and heterozygous benign (TAAAA)n and (TAGAA)n expansions in brain expressed, associated with NEDD4 (BEAN1). Enrichment of the repeat regions in RFC1 and BEAN1 using a Cas9-mediated system clearly distinguished between pathogenic and benign repeat expansions. The haplotype around RFC1 indicated that the (AAGGG)n expansion in our case was on the same ancestral allele as that of European cases. Thus, long-read sequencing facilitates precise genetic diagnosis of diseases with complex repeat structures and various expansions.

    DOI: 10.1038/s10038-020-0733-y

    PubMed

    researchmap

  • Tonsillectomy Improved Therapeutic Response in Anti-SRP Myopathy With Chronic Tonsillitis. 国際誌

    Takuya Ikeda, Hideyuki Takeuchi, Keita Takahashi, Haruko Nakamura, Misako Kunii, Atsuko Katsumoto, Mikiko Tada, Yuichi Higashiyama, Takashi Hibiya, Shigeaki Suzuki, Ichizo Nishino, Shigeru Koyano, Hiroshi Doi, Fumiaki Tanaka

    Frontiers in immunology   11   595480 - 595480   2020年

     詳細を見る

    記述言語:英語  

    Chronic tonsillitis has been attracted attention as a source of abnormal immune responses and a possible trigger of autoimmune diseases such as IgA nephritis, IgA vasculitis, palmoplantar pustulosis, psoriasis, rheumatoid arthritis, Behçet's disease, and myositis. Here we present the first report of anti-signal recognition particle antibody-associated necrotizing myopathy (anti-SRP myopathy) with IgA nephropathy and chronic tonsillitis in which the therapeutic response to intravenous immunoglobulin (IVIG) treatment was dramatically improved after tonsillectomy and accompanied by a rapid increase in ΔIgG, defined as the change in serum IgG levels 2 weeks after the start of IVIG treatment relative to pre-treatment levels. Moreover, serum anti-SRP antibody titers became undetectable after tonsillectomy even though the resected tonsils did not produce anti-SRP antibodies. Tonsillectomy should be considered when chronic tonsillitis is observed in patients with autoimmune diseases showing poor response to treatment, including anti-SRP myopathy.

    DOI: 10.3389/fimmu.2020.595480

    PubMed

    researchmap

  • GGC Repeat Expansion of NOTCH2NLC in Adult Patients with Leukoencephalopathy. 査読 国際誌

    Masaki Okubo, Hiroshi Doi, Ryoko Fukai, Atsushi Fujita, Satomi Mitsuhashi, Shunta Hashiguchi, Hitaru Kishida, Naohisa Ueda, Keisuke Morihara, Akihiro Ogasawara, Yuko Kawamoto, Tatsuya Takahashi, Keita Takahashi, Haruko Nakamura, Misako Kunii, Mikiko Tada, Atsuko Katsumoto, Hiromi Fukuda, Takeshi Mizuguchi, Satoko Miyatake, Noriko Miyake, Junichiro Suzuki, Yasuhiro Ito, Jun Sone, Gen Sobue, Hideyuki Takeuchi, Naomichi Matsumoto, Fumiaki Tanaka

    Annals of neurology   86 ( 6 )   962 - 968   2019年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Leukoencephalopathies comprise a broad spectrum of disorders, but the genetic background of adult leukoencephalopathies has rarely been assessed. In this study, we analyzed 101 Japanese patients with genetically unresolved adult leukoencephalopathy using whole-exome sequencing and repeat-primed polymerase chain reaction for detecting GGC expansion in NOTCH2NLC. NOTCH2NLC was recently identified as the cause of neuronal intranuclear inclusion disease. We found 12 patients with GGC expansion in NOTCH2NLC as the most frequent cause of adult leukoencephalopathy followed by NOTCH3 variants in our cohort. Furthermore, we found 1 case with de novo GGC expansion, which might explain the underlying pathogenesis of sporadic cases. ANN NEUROL 2019;86:962-968.

    DOI: 10.1002/ana.25586

    PubMed

    researchmap

  • Adult-onset vocal cord paralysis in slow-channel congenital myasthenic syndrome. 査読 国際誌

    Haruko Nakamura, Hiroyasu Komiya, Eri Uematsu, Yoshiharu Nakae, Kenichi Tanaka, Misako Kunii, Mikiko Tada, Hideto Joki, Shigeru Koyano, Naomichi Matsumoto, Hiroshi Doi, Hideyuki Takeuchi, Fumiaki Tanaka

    Neurology. Clinical practice   9 ( 5 )   e45-e47 - e47   2019年10月

     詳細を見る

  • 声帯麻痺を呈したSlow Channel Congenital Myasthenic Syndrome(SCCMS)の52歳男性例

    竹歳 卓人, 國井 美紗子, 古宮 裕泰, 多田 美紀子, 北澤 悠, 上木 英人, 土井 宏, 竹内 英之, 田中 章景

    神経治療学   36 ( 6 )   S289 - S289   2019年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • Proteomic analysis of exosome-enriched fractions derived from cerebrospinal fluid of amyotrophic lateral sclerosis patients. 査読 国際誌

    Hayashi N, Doi H, Kurata Y, Kagawa H, Atobe Y, Funakoshi K, Tada M, Katsumoto A, Tanaka K, Kunii M, Nakamura H, Takahashi K, Takeuchi H, Koyano S, Kimura Y, Hirano H, Tanaka F

    Neuroscience research   160   43 - 49   2019年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.neures.2019.10.010

    PubMed

    researchmap

  • Ataxic phenotype with altered CaV3.1 channel property in a mouse model for spinocerebellar ataxia 42. 査読 国際誌

    Shunta Hashiguchi, Hiroshi Doi, Misako Kunii, Yukihiro Nakamura, Misa Shimuta, Etsuko Suzuki, Shigeru Koyano, Masaki Okubo, Hitaru Kishida, Masaaki Shiina, Kazuhiro Ogata, Fumiko Hirashima, Yukichi Inoue, Shun Kubota, Noriko Hayashi, Haruko Nakamura, Keita Takahashi, Atsuko Katsumoto, Mikiko Tada, Kenichi Tanaka, Toshikuni Sasaoka, Satoko Miyatake, Noriko Miyake, Hirotomo Saitsu, Nozomu Sato, Kokoro Ozaki, Kiyobumi Ohta, Takanori Yokota, Hidehiro Mizusawa, Jun Mitsui, Hiroyuki Ishiura, Jun Yoshimura, Shinichi Morishita, Shoji Tsuji, Hideyuki Takeuchi, Kinya Ishikawa, Naomichi Matsumoto, Taro Ishikawa, Fumiaki Tanaka

    Neurobiology of disease   130   104516 - 104516   2019年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Spinocerebellar ataxia 42 (SCA42) is a neurodegenerative disorder recently shown to be caused by c.5144G > A (p.Arg1715His) mutation in CACNA1G, which encodes the T-type voltage-gated calcium channel CaV3.1. Here, we describe a large Japanese family with SCA42. Postmortem pathological examination revealed severe cerebellar degeneration with prominent Purkinje cell loss without ubiquitin accumulation in an SCA42 patient. To determine whether this mutation causes ataxic symptoms and neurodegeneration, we generated knock-in mice harboring c.5168G > A (p.Arg1723His) mutation in Cacna1g, corresponding to the mutation identified in the SCA42 family. Both heterozygous and homozygous mutants developed an ataxic phenotype from the age of 11-20 weeks and showed Purkinje cell loss at 50 weeks old. Degenerative change of Purkinje cells and atrophic thinning of the molecular layer were conspicuous in homozygous knock-in mice. Electrophysiological analysis of Purkinje cells using acute cerebellar slices from young mice showed that the point mutation altered the voltage dependence of CaV3.1 channel activation and reduced the rebound action potentials after hyperpolarization, although it did not significantly affect the basic properties of synaptic transmission onto Purkinje cells. Finally, we revealed that the resonance of membrane potential of neurons in the inferior olivary nucleus was decreased in knock-in mice, which indicates that p.Arg1723His CaV3.1 mutation affects climbing fiber signaling to Purkinje cells. Altogether, our study shows not only that a point mutation in CACNA1G causes an ataxic phenotype and Purkinje cell degeneration in a mouse model, but also that the electrophysiological abnormalities at an early stage of SCA42 precede Purkinje cell loss.

    DOI: 10.1016/j.nbd.2019.104516

    PubMed

    researchmap

  • Novel VRK1 Mutations in a Patient with Childhood-onset Motor Neuron Disease. 査読

    Genpei Yamaura, Yuichi Higashiyama, Kaori Kusama, Misako Kunii, Kenichi Tanaka, Shigeru Koyano, Mitsuko Nakashima, Yoshinori Tsurusaki, Noriko Miyake, Hirotomo Saitsu, Yukiko Iwahashi, Hideto Joki, Naomichi Matsumoto, Hiroshi Doi, Fumiaki Tanaka

    Internal medicine (Tokyo, Japan)   58 ( 18 )   2715 - 2719   2019年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    A 24-year-old Japanese man exhibited slowly progressive gait disturbance from childhood to young adulthood. Physical and physiological examinations showed the involvement of both upper and lower motor neurons, fulfilling the diagnostic criteria for amyotrophic lateral sclerosis (ALS). Mild cognitive impairment and subclinical sensory involvement were also observed. A genetic analysis revealed novel compound heterozygous mutations, c.767C>T (p.Thr256Ile) and c.800A>G (p.Asp267Gly), in the vaccinia-related kinase 1 gene (VRK1). This is the first report of a Japanese patient with a motor neuron disease phenotype caused by VRK1 mutations. This diagnosis should be considered in atypical cases of juvenile-onset and slowly progressive types of motor neuron disease.

    DOI: 10.2169/internalmedicine.2126-18

    PubMed

    researchmap

  • 悪性リンパ腫に対して行ったR-CHOP療法が著効した抗SRP抗体陽性壊死性ミオパチーの71歳男性例

    竹井 暖, 岡本 光生, 古宮 裕泰, 國井 美紗子, 多田 美紀子, 土井 宏, 竹内 英之, 田中 章景

    臨床神経学   59 ( 5 )   304 - 304   2019年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 声帯麻痺を呈したSlow Channel Congenital Myasthenic Syndrome(SCCMS)の52歳男性例

    中村 治子, 國井 美紗子, 古宮 裕泰, 多田 美紀子, 上木 英人, 土井 宏, 竹内 英之, 田中 章景

    臨床神経学   59 ( 4 )   224 - 224   2019年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • POLR3A関連白質ジストロフィーにおける重症骨粗鬆症とその予防策

    古川 宗磨, 鈴木 淳一郎, 西田 卓, 國井 美紗子, 土井 宏, 田中 章景, 伊藤 泰広

    神経治療学   35 ( 6 )   S216 - S216   2018年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • 亜急性進行性認知機能障害と多彩な白質病変を呈した神経梅毒の1例

    國井 美紗子, 伊東 毅, 川口 優花, 中村 治子, 勝元 敦子, 多田 美紀子, 岡本 光生, 玉澤 彰英, 土井 宏, 竹内 英之, 田中 章景

    NEUROINFECTION   23 ( 2 )   232 - 232   2018年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経感染症学会  

    researchmap

  • Genetic analysis of adult leukoencephalopathy patients using a custom-designed gene panel. 査読

    Kunii M, Doi H, Ishii Y, Ohba C, Tanaka K, Tada M, Fukai R, Hashiguchi S, Kishida H, Ueda N, Kudo Y, Kugimoto C, Nakano T, Udaka N, Miyatake S, Miyake N, Saitsu H, Ito Y, Takahashi K, Nakamura H, Tomita-Katsumoto A, Takeuchi H, Koyano S, Matsumoto N, Tanaka F

    Clinical genetics   94 ( 2 )   232 - 238   2018年8月

     詳細を見る

    掲載種別:研究論文(学術雑誌)  

    DOI: 10.1111/cge.13371

    PubMed

    researchmap

    その他リンク: https://onlinelibrary.wiley.com/doi/full-xml/10.1111/cge.13371

  • 運動失調で発症し亜急性に認知症を呈したCreutzfeldt-Jakob病の73歳男性例

    川口 優花, 中村 治子, 國井 美紗子, 勝元 敦子, 多田 美紀子, 岡本 光生, 土井 宏, 田中 章景

    臨床神経学   58 ( 8 )   531 - 531   2018年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Cerebellar ataxia-dominant phenotype in patients with ERCC4 mutations. 査読 国際誌

    Hiroshi Doi, Shigeru Koyano, Satoko Miyatake, Shinji Nakajima, Yuka Nakazawa, Misako Kunii, Atsuko Tomita-Katsumoto, Kayoko Oda, Yukie Yamaguchi, Ryoko Fukai, Shingo Ikeda, Rumiko Kato, Katsuhisa Ogata, Shun Kubota, Noriko Hayashi, Keita Takahashi, Mikiko Tada, Kenichi Tanaka, Mitsuko Nakashima, Yoshinori Tsurusaki, Noriko Miyake, Hirotomo Saitsu, Tomoo Ogi, Michiko Aihara, Hideyuki Takeuchi, Naomichi Matsumoto, Fumiaki Tanaka

    Journal of human genetics   63 ( 4 )   417 - 423   2018年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Autosomal recessive cerebellar ataxias (ARCAs) are clinically and genetically heterogeneous neurological disorders. Through whole-exome sequencing of Japanese ARCA patients, we identified three index patients from unrelated families who had biallelic mutations in ERCC4. ERCC4 mutations have been known to cause xeroderma pigmentosum complementation group F (XP-F), Cockayne syndrome, and Fanconi anemia phenotypes. All of the patients described here showed very slowly progressive cerebellar ataxia and cognitive decline with choreiform involuntary movement, with young adolescent or midlife onset. Brain MRI demonstrated atrophy that included the cerebellum and brainstem. Of note, cutaneous symptoms were very mild: there was normal to very mild pigmentation of exposed skin areas and/or an equivocal history of pathological sunburn. However, an unscheduled DNA synthesis assay of fibroblasts from the patient revealed impairment of nucleotide excision repair. A similar phenotype was very recently recognized through genetic analysis of Caucasian cerebellar ataxia patients. Our results confirm that biallelic ERCC4 mutations cause a cerebellar ataxia-dominant phenotype with mild cutaneous symptoms, possibly accounting for a high proportion of the genetic causes of ARCA in Japan, where XP-F is prevalent.

    DOI: 10.1038/s10038-017-0408-5

    PubMed

    researchmap

  • Cerebrospinal fluid level of Nogo receptor 1 antagonist lateral olfactory tract usher substance (LOTUS) correlates inversely with the extent of neuroinflammation. 査読 国際誌

    Keita Takahashi, Hideyuki Takeuchi, Yuji Kurihara, Hiroshi Doi, Misako Kunii, Kenichi Tanaka, Haruko Nakamura, Ryoko Fukai, Atsuko Tomita-Katsumoto, Mikiko Tada, Yuichi Higashiyama, Hideto Joki, Shigeru Koyano, Kohtaro Takei, Fumiaki Tanaka

    Journal of neuroinflammation   15 ( 1 )   46 - 46   2018年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Although inflammation in the central nervous system is responsible for multiple neurological diseases, the lack of appropriate biomarkers makes it difficult to evaluate inflammatory activities in these diseases. Therefore, a new biomarker reflecting neuroinflammation is required for accurate diagnosis, appropriate therapy, and comprehension of pathogenesis of these neurological disorders. We previously reported that the cerebrospinal fluid (CSF) concentration of lateral olfactory tract usher substance (LOTUS), which promotes axonal growth as a Nogo receptor 1 antagonist, negatively correlates with disease activity in multiple sclerosis, suggesting that variation in LOTUS reflects the inflammatory activities and is a useful biomarker to evaluate the disease activity. To extend this observation, we analyzed the variation of LOTUS in the CSF of patients with bacterial and viral meningitis, which are the most common neuroinflammatory diseases. METHODS: CSF samples were retrospectively obtained from patients with meningitis (n = 40), who were followed up by CSF study at least twice, and from healthy controls (n = 27). Patients were divided into bacterial (n = 14) and viral meningitis (n = 18) after exclusion of eight patients according to the criteria of this study. LOTUS concentrations, total protein levels, and CSF cell counts in the acute and recovery phases were analyzed chronologically. We also used lipopolysaccharide-injected mice as a model of neuroinflammation to evaluate LOTUS mRNA and protein expression in the brain. RESULTS: Regardless of whether meningitis was viral or bacterial, LOTUS concentrations in the CSF of patients in acute phase were lower than those of healthy controls. As the patients recovered from meningitis, LOTUS levels in the CSF returned to the normal range. Lipopolysaccharide-injected mice also exhibited reduced LOTUS mRNA and protein expression in the brain. CONCLUSIONS: CSF levels of LOTUS correlated inversely with disease activity in both bacterial and viral meningitis, as well as in multiple sclerosis, because neuroinflammation downregulated LOTUS expression. Our data strongly suggest that variation of CSF LOTUS is associated with neuroinflammation and is useful as a biomarker for a broader range of neuroinflammatory diseases.

    DOI: 10.1186/s12974-018-1084-x

    PubMed

    researchmap

  • Matrin 3 Is a Component of Neuronal Cytoplasmic Inclusions of Motor Neurons in Sporadic Amyotrophic Lateral Sclerosis. 査読 国際誌

    Mikiko Tada, Hiroshi Doi, Shigeru Koyano, Shun Kubota, Ryoko Fukai, Shunta Hashiguchi, Noriko Hayashi, Yuko Kawamoto, Misako Kunii, Kenichi Tanaka, Keita Takahashi, Yuki Ogawa, Ryo Iwata, Shoji Yamanaka, Hideyuki Takeuchi, Fumiaki Tanaka

    The American journal of pathology   188 ( 2 )   507 - 514   2018年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Mutations in the MATR3 gene have been identified as a cause of familial amyotrophic lateral sclerosis, but involvement of the matrin 3 (MATR3) protein in sporadic amyotrophic lateral sclerosis (SALS) pathology has not been fully assessed. We immunohistochemically analyzed MATR3 pathology in the spinal cords of SALS and control autopsy specimens. MATR3 immunostaining of the motor neuron nuclei revealed two distinct patterns: mild and strong staining. There were no differences in the ratio of mild versus strong nuclear staining between the SALS and control cases. MATR3-containing neuronal cytoplasmic inclusions (NCIs) were observed in 60% of SALS cases. Most motor neurons with MATR3-positive NCIs exhibited a mild nuclear staining pattern. Although 16.8% of NCIs positive for transactivating response region DNA-binding protein 43 (TDP-43) were estimated as double-labeled by MATR3, no MATR3-positive or TDP-43-negative NCIs were observed. Although a previous study found that MATR3-positive NCIs are present only in cases with C9orf72 hexanucleotide repeat expansion, ubiquitin-positive granular NCIs were not observed in the cerebellum, which have been reported as specific to C9orf72-related ALS. Six ALS cases were confirmed to be negative for the GGGGCC hexanucleotide. Our results reveal that MATR3 is a component of TDP-43-positive NCIs in motor neurons, even in SALS, and indicate the broader involvement of MATR3 in ALS pathology and the heterogeneity of TDP-43-positive NCIs.

    DOI: 10.1016/j.ajpath.2017.10.007

    PubMed

    researchmap

  • 産褥期の低髄液圧症候群を契機に発症したと思われた脳静脈血栓症の36歳女性例

    大瀧 浩之, 高橋 慶太, 石田 匡宏, 國井 美紗子, 東山 雄一, 土井 宏, 竹内 英之, 田中 章景

    臨床神経学   57 ( 4 )   187 - 187   2017年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • POLR3A関連白質ジストロフィーの姉妹例

    古川 宗磨, 鈴木 淳一郎, 中井 紀嘉, 西田 卓, 國井 美紗子, 土井 宏, 田中 章景, 伊藤 泰広

    臨床神経学   56 ( Suppl. )   S494 - S494   2016年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Autosomal recessive spinocerebellar ataxias in Japan. 査読

    Fumiaki Tanaka, Hiroshi Doi, Misako Kunii

    Rinsho shinkeigaku = Clinical neurology   56 ( 6 )   395 - 9   2016年6月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    Recent new sequencing techniques allow the identification of novel responsible genes for autosomal recessive spinocerebellar ataxias (ARCAs). However, the same phenotypes are sometimes attributed to the different responsible genes in ARCAs. On the contrary, the same responsible genes may cause heterogeneous phenotypes with respect to the age at onset, symptoms, and the severity of the disease progression. In addition, it is an important issue to clarify whether the gene mutations identified in Caucasian patients with infantile-onset ARCAs are also observed in Japanese patients with adult-onset ARCAs. In this article we review the characteristics of several ARCAs, the existence of which has been recently identified or confirmed in Japan.

    DOI: 10.5692/clinicalneurol.cn-000879

    PubMed

    researchmap

  • 本邦でみられる常染色体劣性遺伝性脊髄小脳変性症

    田中 章景, 土井 宏, 國井 美紗子

    臨床神経学   56 ( 6 )   395 - 399   2016年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    近年のゲノムシークエンス技術の進歩により、常染色体劣性遺伝性脊髄小脳変性症の新たな責任遺伝子が次々と明らかになってきている。しかし、同じような表現型を示していても責任遺伝子が全く異なる場合や、逆に同じ責任遺伝子であっても発症年齢、症状、疾患進行が大きく異なる場合があり、診断は容易ではない。また、欧米の特に小児期発症例において同定された遺伝子変異が、本邦の成人発症例においてもみられるのかどうかは、今後も引き続き検討が必要な課題である。本稿では、主として近年本邦でも存在が確認された比較的まれと考えられる劣性遺伝性脊髄小脳変性症について概説する。(著者抄録)

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2016&ichushi_jid=J01550&link_issn=&doc_id=20160728260001&doc_link_id=130005158857&url=https%3A%2F%2Fci.nii.ac.jp%2Fnaid%2F130005158857&type=CiNii&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00003_1.gif

  • 新規TTC19変異によって生じたCIII欠損症の日本人姉弟2例(Two Japanese siblings with CIII deficiency caused by a novel TTC19 mutation)

    國井 美紗子, 土井 宏, 東山 雄一, 釘本 千春, 松本 直通, 田中 章景

    臨床神経学   55 ( Suppl. )   S452 - S452   2015年12月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • A Japanese case of cerebellar ataxia, spastic paraparesis and deep sensory impairment associated with a novel homozygous TTC19 mutation 査読

    Misako Kunii, Hiroshi Doi, Yuichi Higashiyama, Chiharu Kugimoto, Naohisa Ueda, Junichi Hirata, Atsuko Tomita-Katsumoto, Mari Kashikura-Kojima, Shun Kubota, Midori Taniguchi, Kei Murayama, Mitsuko Nakashima, Yoshinori Tsurusaki, Noriko Miyake, Hirotomo Saitsu, Naomichi Matsumoto, Fumiaki Tanaka

    JOURNAL OF HUMAN GENETICS   60 ( 4 )   187 - 191   2015年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:NATURE PUBLISHING GROUP  

    Mitochondrial complex III (CIII) deficiency comprises a group of complex and heterogeneous genetic disorders. TTC19 mutations constitute a rare cause of CIII deficiency and are associated with neurological disorders in childhood and adulthood. Herein, we describe a 27-year-old Japanese man with cerebellar ataxia, spastic paraparesis, loss of deep sensation, mild frontal lobe dysfunction and transient psychiatric symptoms. Brain magnetic resonance imaging showed cerebellar atrophy and bilateral high-intensity signals in the inferior olives and regions adjacent to periaqueductal gray matter, on T2-weighted images. On whole-exome sequencing, we detected a novel homozygous frameshift mutation c.157_158dup [p.Pro54Alafs* 48] in TTC19. Mitochondrial enzyme assays confirmed mild impairment of CIII enzymatic activity in lymphoblasts, which was consistent with TTC19-related CIII deficiency. His symptoms and radiological findings demonstrated an early stage or mild form of this disease, and further clarify the characteristics of patients with rare TTC19 mutations.

    DOI: 10.1038/jhg.2015.7

    Web of Science

    PubMed

    researchmap

  • Lymphopenia Helps Early Diagnosis of Systemic Lupus Erythematosus for Patients With Psychosis as an Initial Symptom 査読

    Yuhei Chiba, Omi Katsuse, Hiroshige Fujishiro, Ayuko Kamada, Tomoyuki Saito, Takahiro Ikura, Yukitoshi Takahashi, Misako Kunii, Mitsuhiro Takeno, Yoshio Hirayasu

    Psychosomatics   56 ( 1 )   85 - 88   2015年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier Inc.  

    DOI: 10.1016/j.psym.2013.07.001

    Scopus

    PubMed

    researchmap

  • Lymphopenia Helps harly Diagnosis of Systemic Lupus Erythematosus for Patients With Psychosis as an Initial Symptom 査読

    Yuhei Chiba, Omi Katsuse, Hiroshige Fujishiro, Ayuko Kamada, Tomoyuki Saito, Takahiro Ikura, Yukitoshi Takahashi, Misako Kunii, Mitsuhiro Takeno, Yoshio Hirayasu

    PSYCHOSOMATICS   56 ( 1 )   85 - 88   2015年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE INC  

    DOI: 10.1016/j.psym.2013.07.001

    Web of Science

    PubMed

    researchmap

  • IgA腎症を合併したCADASILの37歳男性例

    春日井 裕美, 草間 香里, 山浦 弦平, 國井 美紗子, 東山 雄一, 土井 宏, 鈴木 ゆめ, 田中 章景

    臨床神経学   55 ( 1 )   65 - 65   2015年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 脳脊髄液抗GAD抗体測定の有用性の検討

    古宮 裕泰, 國井 美紗子, 岡本 光生, 田中 章景, 高橋 竜哉

    臨床神経学   54 ( Suppl. )   S251 - S251   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 精神疾患患者における脳梗塞診断困難例の特徴

    國井 美紗子, 古宮 裕泰, 岡本 光生, 田中 章景, 高橋 竜哉

    臨床神経学   54 ( Suppl. )   S130 - S130   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 脳卒中患者における回復期リハビリテーション病院からの退院先

    高橋 竜哉, 高瀬 昌浩, 古宮 裕泰, 國井 美紗子, 岡本 光生, 田中 章景

    臨床神経学   54 ( Suppl. )   S79 - S79   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 脳出血におけるEPA/AA比の検討

    岡本 光生, 古宮 裕泰, 國井 美紗子, 田中 章景, 高橋 竜哉

    臨床神経学   54 ( Suppl. )   S75 - S75   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 内包後脚に再発を繰り返した低血糖性片麻痺の1例

    窪田 瞬, 平田 順一, 小島 麻里, 國井 美紗子, 冨田 敦子, 釘本 千春, 土井 宏, 上田 直久, 田中 章景

    脳卒中   36 ( 5 )   370 - 373   2014年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本脳卒中学会  

    症例は79歳男性。糖尿病で内服加療を行っていたが、突然発症の右不全片麻痺を来し当院に救急搬送された。頭部MRI拡散強調画像で左内包後脚に高信号を認めた。血糖が30mg/dlと著明に低下しており50%グルコースを静注したところ症状は速やかに消失し、片麻痺の原因は低血糖によるものと考えられた。患者は過去にも低血糖による内包後脚のMRI異常信号を呈し、右不全片麻痺を発症していた。低血糖発作による脳卒中様の片麻痺は過去にも報告がみられるが、同一部位に繰り返しMRI異常信号を認めた例はこれまでにない。内包後脚が低血糖への脆弱性が高い脳組織の一つであることが示された。(著者抄録)

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2014&ichushi_jid=J01786&link_issn=&doc_id=20141003400010&doc_link_id=%2Fdh3strok%2F2014%2F003605%2F010%2F0370-0373%26dl%3D0&url=https%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Fdh3strok%2F2014%2F003605%2F010%2F0370-0373%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

  • 下顎歯肉癌に対する超選択的動注療法後に失語症を呈した84歳男性例

    國井 美紗子, 工藤 洋祐, 冨田 敦子, 鈴木 ゆめ, 田中 章景

    臨床神経学   53 ( 10 )   852 - 852   2013年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Social isolation perturbs experience-driven synaptic glutamate receptor subunit 4 delivery in the developing rat barrel cortex 査読

    Tomoyuki Miyazaki, Misako Kunii, Susumu Jitsuki, Akane Sano, Yoshiyuki Kuroiwa, Takuya Takahashi

    EUROPEAN JOURNAL OF NEUROSCIENCE   37 ( 10 )   1602 - 1609   2013年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    In neonates, the stress of social isolation can alter developing neural circuits and cause mental illness. However, the molecular and cellular bases for these effects are poorly understood. Experience-driven synaptic AMPA receptor delivery is crucial for circuit organisation during development. In the rat, whisker experience drives the delivery of glutamate receptor subunit 4 (GluA4) but not glutamate receptor subunit 1 (GluA1) to layer 42/3 pyramidal synapses in the barrel cortex during postnatal day (P)810, whereas GluA1 but not GluA4 is delivered to these synapses during P1214. We recently reported that early social isolation disrupts experience-driven GluA1 delivery to layer 42/3 pyramidal synapses during P1214. Here, we report that neonatal isolation affects even earlier stages of development by preventing experience-dependent synaptic GluA4 delivery. Thus, social isolation severely affects synaptic maturation throughout early postnatal development.

    DOI: 10.1111/ejn.12188

    Web of Science

    PubMed

    researchmap

  • Anti-glutamate receptor ɛ2 antibodies in psychiatric patients with anti-thyroid autoantibodies--a prevalence study in Japan. 査読

    Chiba Yuhei, Katsuse Omi, Takahashi Yukitoshi, Yoneda Makoto, Kunii Misako, Ihata Atsushi, Ueda Atsuhisa, Takeno Mitsuhiro, Togo Takashi, Hirayasu Yoshio

    Neuroscience letters   534   217 - 22   2013年2月

     詳細を見る

    記述言語:英語  

    Patients with anti-thyroid antibodies (ATAs) present various kinds of psychiatric conditions. When these psychiatric patients with ATAs (PPATs) show responsiveness to immunotherapy, they are frequently diagnosed with a diffuse progressive type of Hashimoto's encephalopathy (HE). Anti-glutamate receptor ɛ2 subunit (GluRɛ2) antibodies have previously been reported in HE patients. However, it is unclear whether there is any relationship between PPATs, including HE patients, and anti-GluRɛ2 antibodies. We investigated anti-GluRɛ2 antibodies in the serum and cerebrospinal fluid (CSF) of 15 PPATs, and we compared the results with those of 11 patients with neuropsychiatric systemic lupus erythematosus (NPSLE), an anti-glutamate receptor antibody-related disease. We then compared the neuropsychiatric symptoms between the PPATs with and without anti-GluRɛ2 antibodies. The prevalence of anti-GluRɛ2 antibodies was significantly higher in the CSF than in the serum of PPATs (41.7% versus 6.7%; p=0.040). The prevalence of anti-GluRɛ2 antibodies was slightly higher in the CSF of PPATs than NPSLE patients. PPAT-GluR(+)s showed a significantly higher prevalence of emotional instability (100%

    DOI: 10.1016/j.neulet.2012.10.060

    PubMed

    researchmap

  • Anti-glutamate receptor ɛ2 antibodies in psychiatric patients with anti-thyroid autoantibodies--a prevalence study in Japan. 査読

    Chiba Y, Katsuse O, Takahashi Y, Yoneda M, Kunii M, Ihata A, Ueda A, Takeno M, Togo T, Hirayasu Y

    Neuroscience letters   534   217 - 222   2013年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.neulet.2012.10.060

    Web of Science

    PubMed

    researchmap

  • Developmental AMPA receptor subunit specificity during experience-driven synaptic plasticity in the rat barrel cortex 査読

    Tomoyuki Miyazaki, Misako Kunii, Hirobumi Tada, Akane Sano, Yoshiyuki Kuroiwa, Takahisa Goto, Roberto Malinow, Takuya Takahashi

    BRAIN RESEARCH   1435   1 - 7   2012年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE BV  

    During early postnatal brain development, experience-driven delivery of AMPA receptors to synapses participates in the initial organization of conical function. By combining virus-mediated in vivo gene delivery with in vitro whole cell recordings, we identified a subunit-specific developmental program of experience-driven AMPA receptor delivery to synapses in rat barrel cortex. We expressed green fluorescent protein (GFP)-tagged AMPA receptors (GFP-GluR1, or GFP-GluR4) into layer 2/3 pyramidal neurons at two distinct developmental periods, postnatal day (P)8-P10 and P12-P14. Two days after viral infection, acute brain slices were prepared, and synaptic transmission from layer 4 to layer 2/3 was analyzed by whole cell recordings. We found that whisker experience drives GluR4 but not GluR1 into these synapses early in postnatal development (P8-1310). However, at P12-14, GluR1 but not GluR4 is delivered into synapses by whisker experience. This precise developmental plan suggests unique plasticity properties endowed in different AMPA receptor subunits which shape the initial experience-driven organization of cortical function. (C) 2011 Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.brainres.2011.11.033

    Web of Science

    PubMed

    researchmap

  • ALSと骨代謝の経時的変化について

    釘本 千春, 馬場 泰尚, 土井 宏, 亀田 知明, 國井 美紗子, 大場 ちひろ, 鈴木 ゆめ, 黒岩 義之

    臨床神経学   50 ( 12 )   1200 - 1200   2010年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 神経疾患を有する市中誤嚥性肺炎患者の臨床像と予後予測

    亀田 知明, 土井 宏, 大場 ちひろ, 國井 美紗子, 釘本 千春, 馬場 泰尚, 鈴木 ゆめ, 黒岩 義之

    臨床神経学   50 ( 12 )   1217 - 1217   2010年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • [Voltage-gated potassium channel antibodies, voltage-gated calcium channel antibodies]. 査読

    Kunii M, Doi H, Kuroiwa Y

    Nihon rinsho. Japanese journal of clinical medicine   68 Suppl 6   629 - 632   2010年6月

     詳細を見る

  • 【広範囲血液・尿化学検査免疫学的検査[第7版] その数値をどう読むか】免疫学的検査 自己抗体 抗VGKC抗体、抗VGCC抗体

    國井 美紗子, 土井 宏, 黒岩 義之

    日本臨床   68 ( 増刊6 広範囲血液・尿化学検査 免疫学的検査(3) )   629 - 632   2010年6月

  • 慢性進行性の歩行障害と認知症を呈した多発性海綿状血管腫の77歳男性例

    岸本 久美子, 亀田 知明, 土井 宏, 藤井 香南, 國井 美紗子, 大場 ちひろ, 釘本 千春, 馬場 泰尚, 鈴木 ゆめ, 黒岩 義之

    日本内科学会関東地方会   568回   43 - 43   2009年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本内科学会-関東地方会  

    researchmap

  • 大脳皮質基底核変性症様の症候を呈したクロイツフェルト・ヤコブ病の74歳男性例

    杉山 美紀子, 岸田 日帯, 国井 美紗子, 鈴木 ゆめ, 黒岩 義之

    臨床神経学   49 ( 9 )   602 - 602   2009年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 両側側頭葉に出血を伴った急性散在性脳脊髄炎の1例

    中橋 秀文, 國井 美紗子, 大場 ちひろ, 亀田 知明, 土井 宏, 釘本 千春, 馬場 泰尚, 鈴木 ゆめ, 黒岩 義之

    日本内科学会関東地方会   564回   31 - 31   2009年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本内科学会-関東地方会  

    researchmap

  • 瞳孔科学の新しい展開 パーキンソン病、多系統萎縮症、脊髄小脳変性症における薬物点眼試験の検討

    宮地 洋輔, 杉山 美紀子, 馬場 泰尚, 國井 美紗子, 松本 千尋, 岸田 日帯, 上田 直久, 島村 めぐみ, 鈴木 ゆめ, 黒岩 義之

    日本自律神経学会総会プログラム・抄録集   61回   111 - 111   2008年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本自律神経学会  

    researchmap

▼全件表示

MISC

  • 自己誘発性低酸素(いわゆるchoking game)によるてんかん発作様イベントとてんかん、前頭部脳波異常が併存した1例

    池谷 直樹, 武下 草生子, 渡辺 好宏, 杉山 鮎子, 中川 牧子, 天貝 徹, 東島 威史, 白石 洋子, 國井 美紗子, 北澤 悠, 山本 哲哉

    臨床神経生理学   47 ( 5 )   435 - 435   2019年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本臨床神経生理学会  

    researchmap

  • 多発性脳梗塞を呈する血管内リンパ腫で発症したメトトレキサート関連リンパ増殖性疾患の1例

    國井 美紗子, 大瀧 浩之, 浅野 徹也, 小川 有紀, 高橋 慶太, 東山 雄一, 土井 宏, 竹内 英之, 田中 章景

    神経免疫学   22 ( 1 )   122 - 122   2017年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経免疫学会  

    researchmap

  • 閉塞性尿路感染症により意識障害を呈した74歳男性例

    松永 祐己, 大瀧 浩之, 東山 雄一, 高橋 慶太, 國井 美紗子, 上木 英人, 土井 宏, 竹内 英之, 田中 章景

    臨床神経学   57 ( 10 )   631 - 631   2017年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 23価肺炎球菌ワクチン接種後に血清型34による肺炎球菌性髄膜炎をきたした1例

    浅野 徹也, 國井 美紗子, 大瀧 浩之, 小川 有紀, 高橋 慶太, 東山 雄一, 土井 宏, 竹内 英之, 田中 章景

    NEUROINFECTION   21 ( 2 )   208 - 208   2016年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経感染症学会  

    researchmap

  • 再発性多発軟骨炎による脳症と診断した72歳男性例

    澁谷 真弘, 國井 美紗子, 東山 雄一, 齊藤 麻美, 川本 裕子, 田中 健一, 上木 英人, 田中 章景

    臨床神経学   56 ( 7 )   514 - 514   2016年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 慢性活動性EBV感染症による末梢神経障害の18歳女性例

    齊藤 麻美, 草間 香里, 東山 雄一, 國井 美紗子, 田中 健一, 上木 英人, 児矢野 繁, 田中 章景

    臨床神経学   56 ( 2 )   129 - 129   2016年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 脳炎を合併した再発性多発軟骨炎の1例

    沼田 恵美, 井上 雄介, 渡邊 友也, 山口 由衣, 相原 道子, 國井 美紗子, 吉見 竜介

    日本皮膚科学会雑誌   126 ( 2 )   193 - 193   2016年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本皮膚科学会  

    researchmap

  • 脳炎後難治性てんかんの意識消失発作に対し免疫療法が有効で抗NMDAR抗体の関与が示唆された症例

    國井 美紗子, 田中 健一, 多田 美紀子, 窪田 瞬, 東山 雄一, 上木 英人, 児矢野 繁, 高橋 幸利, 田中 章景

    神経免疫学   20 ( 1 )   133 - 133   2015年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経免疫学会  

    researchmap

  • 血管炎性ニューロパチーと診断したB型肝炎ウイルスキャリアの33歳女性例

    草間 香里, 東山 雄一, 山浦 弦平, 國井 美紗子, 田中 健一, 上木 英人, 児矢野 繁, 田中 章景

    臨床神経学   55 ( 8 )   617 - 617   2015年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 選択的タイプライティング障害を呈した左前頭葉梗塞の78歳男性例

    東山 雄一, 山浦 弦平, 草間 香里, 國井 美紗子, 田中 健一, 上木 英人, 田中 章景

    高次脳機能研究   35 ( 1 )   90 - 90   2015年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本高次脳機能障害学会  

    researchmap

  • 広汎な白質脳症を呈しステロイドパルス療法が著効した橋本脳症の85歳女性例

    國井 美紗子, 古宮 裕泰, 岡本 光生, 高橋 竜哉

    臨床神経学   54 ( 3 )   248 - 248   2014年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 両側側頭葉に出血を伴った急性散在性脳脊髄炎の1例

    國井 美紗子, 中橋 秀文, 大場 ちひろ, 亀田 知明, 土井 宏, 釘本 千春, 馬場 泰尚, 鈴木 ゆめ, 黒岩 義之

    日本内科学会雑誌   99 ( 7 )   1656 - 1658   2010年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:一般社団法人 日本内科学会  

    先行感染を伴い,両側側頭葉に出血を伴う髄膜脳炎を呈し,同時に脊髄病変を認めた急性散在性脳脊髄炎(acute disseminated encephalomyelitis,ADEM)の男性例.出血を伴う激症型ADEMでは予後不良であることが知られているが,本例は発症早期よりステロイド治療を行い良好な経過をとった稀なケースであると考えられる.<br>

    DOI: 10.2169/naika.99.1656

    CiNii Books

    researchmap

  • 瞳孔科学の新しい展開 パーキンソン病、多系統萎縮症、脊髄小脳変性症における薬物点眼試験の検討

    宮地 洋輔, 杉山 美紀子, 馬場 泰尚, 國井 美紗子, 松本 千尋, 岸田 日帯, 上田 直久, 島村 めぐみ, 鈴木 ゆめ, 黒岩 義之

    自律神経   46 ( 5 )   420 - 423   2009年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本自律神経学会  

    パーキンソン病(PD)、多系統萎縮症(MSA)に薬物点眼検査を施行し、疾患間に相違ないか検討した。薬物点眼試験を施行したPD 24例、オリーブ橋小脳萎縮症(OPCA)33例、線状体黒質変性症(SND)14例、シャイ・ドレーガー症候群(SDS)5例を対象とした。点眼薬は1.25%エピネフリンまたは1%フェニレフリン(E・P)、5%チラミン(T)、および5%コカイン(C)を使用した。E・Pの過剰散瞳は、PD 22例中10例.OPCA 32例中16例、SND 15例中7例、SDS 5例中3例で、節後性障害でTの反応低下を伴う例はPD 3例、OPCA 2例、SND 1例、SDS 1例、Cでの反応低下例はPD 5例、OPCA 7例、SND 5例、SDS 4例であった。瞳孔反応異常は他の自律神経障害と無関係で、他の障害に先行する症例も認めた。点眼試験は、鑑別には有用ではなかった。

    researchmap

▼全件表示

講演・口頭発表等

  • The effects of identified CACNA1G mutations on channel functions in neurodevelopmental disorders

    國井 美紗子

    The 42th Annual Meeting of the Japan Neuroscience Society  2019年7月 

     詳細を見る

    記述言語:英語   会議種別:ポスター発表  

    researchmap

  • 緑膿菌感染による肥厚性硬膜炎に伴って硬膜下水腫を呈した78歳女性例

    國井 美紗子

    第228回日本神経学会関東・甲信越地方会  2019年3月 

     詳細を見る

    記述言語:日本語   会議種別:口頭発表(一般)  

    researchmap

  • De novo CACNA1G mutations in neurodevelopmental disorders

    The 60th Annual Meeting of the Japanese Society of Neurology  2019年5月 

     詳細を見る

    記述言語:英語   会議種別:ポスター発表  

    researchmap

  • Characteristics of five CADASIL patients including two patients with novel NOTCH3 mutations.

    KUNII Misako

    The 59th Annual Meeting of the Japanese Society of Neurology  2018年5月 

     詳細を見る

    記述言語:英語   会議種別:ポスター発表  

    researchmap

  • 亜急性進行性認知機能障害と多彩な白質病変を呈した神経梅毒の1例

    國井 美紗子

    第23回日本神経感染症学会総会・学術大会  2018年10月 

     詳細を見る

    記述言語:日本語   会議種別:口頭発表(一般)  

    researchmap

共同研究・競争的資金等の研究課題

  • 扁桃体腫大を伴う側頭葉てんかんの病態背景の解明と新規治療法の開発

    研究課題/領域番号:21K07419  2021年4月 - 2024年3月

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    國井 美紗子, 土井 宏, 東山 雄一, 田中 章景, 多田 美紀子

      詳細を見る

    配分額:4160000円 ( 直接経費:3200000円 、 間接経費:960000円 )

    本研究では、TLE-AE患者から得られた髄液検体及び切除脳検体を用いた網羅的解析を行い、TLE-AEの背景疾患の解明及び適切な治療法の開発を目指している。
    これまで20名以上の患者の収集に成功している。扁桃体腫大を伴う側頭葉てんかん患者に対し、プロトコールに則り画像検査、髄液検査などの検査を施行し、炎症所見を認めた患者に対して適切な免疫治療を行っている。抗LGI1抗体や抗GAD抗体などの特定の自己抗体が検出され免疫治療が奏功した症例も存在し、全体に占める辺縁系脳炎の割合は高くないものの一定数存在していることが想定される。扁桃体腫大を伴いてんかんを主徴として慢性に経過する症例では、適切な診断をうけていない患者がまだ存在する可能性が考えられ、引き続き患者の収集、解析を続ける予定である。
    一方で、髄液などに異常所見がなく、少量の抗てんかん薬でコントロール良好な症例も存在した。もともと扁桃体腫大を伴う側頭葉てんかんは、難治性の側頭葉てんかん患者より発見されてきた経緯があるが、実際には難治ではない症例でも扁桃体腫大を認める症例も散見することも確認された。当初より背景病態は多岐にわたることが推測されていたが、さらにコントロール良好なてんかん患者で扁桃体腫大を認める症例についても積極的にデータを収集し、背景疾患の解明に務める。
    また、外科的切除はまだ施行に至っていないが、今後手術を検討している症例が存在し、検体が得られればさらに病理学的評価を行う予定である。

    researchmap

  • 脊髄小脳失調症42型疾患修飾治療開発と光遺伝学的手法を用いた病態基盤の解明

    研究課題/領域番号:21K07298  2021年4月 - 2024年3月

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    土井 宏, 竹内 英之, 田中 章景, 石川 太郎, 國井 美紗子

      詳細を見る

    配分額:4160000円 ( 直接経費:3200000円 、 間接経費:960000円 )

    申請者らは研究対象としてきた常染色体優性脊髄小脳失調症(SCA)大家系において、新型DNAシーケンサーを用いて低電位活性化型のT型電位依存性カルシウムチャネル(VGCC)の一種であるCaV3.1をコードするCACNA1Gのミスセンスバリアント、p.Arg1715His(R1715H) を同定した。単一アミノ酸のミスセンスバリアントであるR1715Hにより実際に神経変性が惹起されるかは不明であり、申請者らはその証明には動物モデルの作成が必須であると考え、R1715Hと同等のR1723HバリアントをCRISPR/Cas9を用いたゲノム編集により導入したノックインマウス(Cacna1g_R1723H_KIマウス)を作成した。これまでに申請者らは構造モデリング、ヒト病理検体解析、培養細胞実験を継続するとともにCacna1g_R1723H_KIマウスの多面的解析を行い、このバリアントによるタンパク質凝集性には変化がないこと、行動解析において患者と同様の緩徐進行性の失調症状を示すこと、プルキンエ細胞(PC)の進行性変性を呈すること、PCおよび下オリーブ核神経細胞がカルシウム電流異常を含む電気生理学的異常を呈することを示し、SCA42の表現型を良好に再現するモデルを確立してきた。本研究ではCacna1g_R1723H_KIマウスにT型VGCC修飾薬の投与を行い、その効果を表現型解析、病理学的解析、RNA発現解析など多面的に検証することにより、新たな疾患修飾治療法を開発し疾患克服への道筋をつけること、また光遺伝学的手法を用いて神経変性の病態基盤をin vivoのレベルで解明することを目的とする。

    researchmap

  • T型カルシウムチャネル異常が引き起こす神経細胞死の病態機序解明

    2019年4月 - 2021年3月

    文部科学省研究振興局  科学研究費助成事業(若手研究) 

    國井 美紗子

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    researchmap

  • 脊髄小脳失調症新規モデルマウスを用いた病態解明と治療法開発

    研究課題/領域番号:18K07503  2018年4月 - 2021年3月

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    土井 宏, 竹内 英之, 田中 章景, 國井 美紗子

      詳細を見る

    配分額:4290000円 ( 直接経費:3300000円 、 間接経費:990000円 )

    申請者らは脊髄小脳失調症42型(SCA42)の原因として知られるCACNA1GのR1715H変異をCRISPR/Cas9を用いたゲノム編集により導入したノックインマウス(Cacna1g_R1723H_KIマウス)を作成した。変異ノックインマウスは失調症状、Purkinje細胞(PC)脱落を呈した。PCの電気生理学的検査において、ホモのノックインマウスで電流電圧曲線の変化、rebound firingの減少を認めた。このように、申請者らはSCA42モデルマウスの確立に成功した。さらにT型VGCC機能修飾薬の経口投与を行い、ヘテロノックインマウスの失調症状、神経変性が改善を示唆する結果を得た。

    researchmap

  • 電位依存性カルシウムチャネル関連疾患の分子病態基盤の解明

    2017年4月 - 2019年3月

    文部科学省研究振興局  科学研究費助成事業(若手研究(B)) 

    國井 美紗子

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    researchmap

  • 脊髄小脳変性症の遺伝背景の解析と新規遺伝子同定に基づく病態解明

    研究課題/領域番号:15K09344  2015年4月 - 2018年3月

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    土井 宏, 田中 章景, 田中 健一, 國井 美紗子, 松本 直通, 石川 欽也

      詳細を見る

    配分額:4680000円 ( 直接経費:3600000円 、 間接経費:1080000円 )

    本研究は、既知責任遺伝子に変異を認めない家族例、孤発例の脊髄小脳変性症(spinocerebellar degeneration: SCD)のエクソーム解析を通して、SCDの新規責任遺伝子を解明することを目的とした。
    我々は常染色体優性遺伝家系において、電位依存性カルシウムチャネルCACNA1Gのミスセンス変異を同定した。しかしCACNA1G変異例については我々の研究実施中に他グループから論文報告がなされたため、病理所見を中心に論文を作成中である。また、劣性遺伝性家系、孤発性SCD例の解析では、3家系4名においてこれまでにほとんどSCDの原因として報告のないERCC4変異を同定し報告した。

    researchmap

▼全件表示